The etiology of hip fractures is multifactorial and includes bone and fall-related factors. Low bone mineral density (BMD) and BMD-related and BMD-independent geometric components of bone strength, evaluated by hip strength analysis (HSA) and finite element analysis analyses on dual-energy X-ray absorptiometry (DXA) images, and ultrasound parameters are related to the presence and incidence of hip fracture. In addition, clinical risk factors contribute to the risk of hip fractures, independent of BMD. They are included in the fracture risk assessment tool (FRAX) case finding algorithm to estimate in the individual patient the 10-year risk of hip fracture, with and without BMD. Fall risks are not included in FRAX, but are included in other case finding tools, such as the Garvan algorithm, to predict the 5- and 10-year hip fracture risk. Hormones, cytokines, growth factors, markers of bone resorption and genetic background have been related to hip fracture risk. Vitamin D deficiency is endemic worldwide and low serum levels of 25-hydroxyvitamin D [25(OH)D] predict hip fracture risk. In the context of hip fracture prevention calculation of absolute fracture risk using clinical risks, BMD, bone geometry and fall-related risks is feasible, but needs further refinement by integrating bone and fall-related risk factors into a single case finding algorithm for clinical use.
Abdallah, B.M., Stilgren, L.S., Nissen, N., Kassem, M., Jorgensen, H.R. and Abrahamsen, B. ( 2005) Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif Tissue Int76: 90-97.
2.
Ahlborg, H.G., Nguyen, N.D., Nguyen, T.V., Center, J.R. and Eisman, J.A. ( 2005) Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res20: 1820-1827.
3.
Ammann, P., Badoud, I., Barraud, S., Dayer, R. and Rizzoli, R. ( 2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res22: 1419-1425.
4.
Barkmann, R., Dencks, S., Laugier, P., Padilla, F., Brixen, K., Ryg, J. et al. (2009) Femur ultrasound (FemuUS)-first clinical results on hip fracture discrimination and estimation of femoral BMD. Osteoporos Int: Epub 20 Aug 2009.
5.
Bates, D.W., Black, D.M. and Cummings, S.R. ( 2002) Clinical use of bone densitometry: clinical applications . JAMA288: 1898-1900.
6.
Beck, T. ( 2003) Measuring the structural strength of bones with dual-energy x-ray absorptiometry: principles, technical limitations, and future possibilities . Osteoporos Int14(Suppl 5): S81-88.
7.
Beck, T.J., Mourtada, F.A., Ruff, C.B., Scott Jr, W.W. and Kao, G. ( 1998) Experimental testing of a DEXA-derived curved beam model of the proximal femur. J Orthop Res16: 394-398.
8.
Beck, T.J., Looker, A.C., Ruff, C.B., Sievanen, H. and Wahner, H.W. ( 2000) Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey Dual-Energy X-Ray Absorptiometry Data. J Bone Miner Res15: 2297-2304.
9.
Bischoff Ferrari, H.A., Dawson Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y. et al. (2004) Effect of vitamin D on falls: a meta-analysis . JAMA291: 1999-2006.
10.
Bischoff Ferrari, H.A., Willett, W.C., Wong, J.B., Giovannucci, E., Dietrich, T. and Dawson Hughes, B. ( 2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA293: 2257-2264.
11.
Black, D.M., Cummings, S.R., Karpf, D.B., Cauley, J.A., Thompson, D.E., Nevitt, M.C. et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet348: 1535-1541.
12.
Black, D.M., Thompson, D.E., Bauer, D.C., Ensrud, K., Musliner, T., Hochberg, M.C. et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. Fit Research Group . J Clin Endocrinol Metab85: 4118-4124.
13.
Black, D.M., Steinbuch, M., Palermo, L., Dargent-Molina, P., Lindsay, R., Hoseyni, M.S. et al. (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int12: 519-528.
14.
Black, D.M., Delmas, P.D., Eastell, R., Reid, I.R., Boonen, S., Cauley, J.A. et al. (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med356: 1809-1822.
15.
Bliuc, D., Nguyen, N.D., Milch, V.E., Nguyen, T.V., Eisman, J.A. and Center, J.R.(2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA301: 513-521.
16.
Boonen, S., Rosen, C., Bouillon, R., Sommer, A., McKay, M., Rosen, D. et al. (2002) Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab87: 1593-1599.
17.
Bouxsein, M.L. ( 2008) Technology insight: noninvasive assessment of bone strength in osteoporosis. Nat Clin Pract Rheumatol4: 310-318.
18.
Brauer, C.A., Coca Perraillon, M., Cutler, D.M. and Rosen, A.B.(2009) Incidence and mortality of hip fractures in the United States. JAMA302: 1573-1579.
19.
Bruyere, O., Varela, A.R., Adami, S., Detilleux, J., Rabenda, V., Hiligsmann, M. et al. (2009) Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women. Eur J Epidemiol: Epub 29 Aug 2009.
20.
Bryan, R., Nair, P.B. and Taylor, M.(2009) Use of a statistical model of the whole femur in a large scale, multi-model study of femoral neck fracture risk. J Biomech42: 2171-2176.
21.
Burge, R., Dawson Hughes, B., Solomon, D.H., Wong, J.B., King, A. and Tosteson, A. ( 2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res22: 465-475.
22.
Cauley, J.A., Lacroix, A.Z., Wu, L., Horwitz, M., Danielson, M.E., Bauer, D.C. et al. (2008) Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med149: 242-250.
23.
Center, J.R. and Eisman, J.A. ( 2008) Genetics of osteoporosis, In: Miller, P. and Papapoulos, S. (eds). ASBMR’s primer on the metabolic bone diseases and disorders of mineral metabolism, Vol. 7, American Society for Bone and Mineral Research: Washington.
24.
Center, J.R., Bliuc, D., Nguyen, T.V. and Eisman, J.A. ( 2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA297: 387-394.
25.
Chang, J.T., Morton, S.C., Rubenstein, L.Z., Mojica, W.A., Maglione, M., Suttorp, M.J. et al. (2004) Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials . BMJ328: 680.
26.
Chapurlat, R.D., Garnero, P., Breart, G., Meunier, P.J. and Delmas, P.D. ( 2000) Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS Study. Bone27: 283-286.
27.
Chapuy, M.C., Arlot, M.E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S. et al. (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med327: 1637-1642.
28.
Cummings, S.R., Nevitt, M.C., Browner, W.S., Stone, K., Fox, K.M., Ensrud, K.E. et al. (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med332: 767-773.
29.
Cummings, S.R., Black, D.M., Thompson, D.E., Applegate, W.B., Barrett Connor, E., Musliner, T.A. et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA280: 2077-2082.
30.
Cummings, S.R., San Martin, J., Mcclung, M.R., Siris, E.S., Eastell, R., Reid, I.R. et al. (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med361: 756-765.
31.
Dargent Molina, P., Favier, F., Grandjean, H., Baudoin, C., Schott, A.M., Hausherr, E. et al. (1996) Fall-related factors and risk of hip fracture: the EPIDOS Prospective Study. Lancet348: 145-149.
32.
Deluca, H.F. ( 2008) Evolution of our understanding of vitamin D. Nutr Rev66: S73-87.
33.
Dong, S.S., Liu, X.G., Chen, Y., Guo, Y., Wang, L., Zhao, J. et al. (2009) Association analyses of RANKL/ RANK/OPG gene polymorphisms with femoral neck compression strength index variation in caucasians. Calcif Tissue Int85: 104-112.
34.
Ensrud, K.E., Ewing, S.K., Taylor, B.C., Fink, H.A., Stone, K.L., Cauley, J.A. et al. (2007) Frailty and risk of falls, fracture, and mortality in older women: the Study of Osteoporotic Fractures. J Gerontol A Biol Sci Med Sci62: 744-751.
35.
Faulkner, K.G., Wacker, W.K., Barden, H.S., Simonelli, C., Burke, P.K., Ragi, S. et al. (2006) Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int17: 593-599.
36.
Garnero, P., Hausherr, E., Chapuy, M.C., Marcelli, C., Grandjean, H., Muller, C. et al. (1996) Markers of bone resorption predict hip fracture in elderly women: the Epidos Prospective Study. J Bone Miner Res11: 1531-1538.
37.
Garnero, P., Munoz, F., Sornay Rendu, E. and Delmas, P.D. ( 2007) Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women . The OFELY Study. Bone40: 716-722.
38.
Garvan Medical Research Institute, O.B.B.P. Fracture Risk Calculator.
39.
Geel Van, T.A.C.M., Helden Van, S., Geusens, P.P., Winkens, B. and Dinant, G.J.(2009) Clinical subsequent fractures cluster in time after first fractures . Ann Rheum Dis68: 99-102: Epub 2008 Aug 2003.
40.
Greenspan, S.L., Myers, E.R., Kiel, D.P., Parker, R.A., Hayes, W.C. and Resnick, N.M. ( 1998) Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med104: 539-545.
41.
Helden Van, S., Cals, J., Kessels, F., Brink, P., Dinant, G.J. and Geusens, P. ( 2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int17: 348-354.
42.
Helden Van, S., Geel Van, A.C.M., Geusens, P.P., Kessels, A., Nieuwenhuijzen Kruseman, A.C. and Brink, P.R. ( 2008) Bone and fall-related fracture risks in women and men with a recent clinical fracture. J Bone Joint Surg Am90: 241-248.
43.
Ismail, A.A., Pye, S.R., Cockerill, W.C., Lunt, M., Silman, A.J., Reeve, J. et al. (2002) Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int13: 565-571.
44.
Kanis, J.A., McCloskey, E.V., Johansson, H., Strom, O., Borgstrom, F. and Oden, A. ( 2008) Case finding for the management of osteoporosis with FRAX- assessment and intervention thresholds for the UK. Osteoporos Int19: 1395-1408.
45.
Kaptoge, S., Beck, T.J., Reeve, J., Stone, K.L., Hillier, T.A., Cauley, J.A. et al. (2008) Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res23: 1892-1904.
46.
Karlsson, M.K., Johnell, O., Nilsson, B.E., Sernbo, I. and Obrant, K.J. ( 1993) Bone mineral mass in hip fracture patients. Bone14: 161-165.
47.
Keaveny, T.M. and Bouxsein, M.L. ( 2008) Theoretical implications of the biomechanical fracture threshold. J Bone Miner Res23: 1541-1547.
48.
Keaveny, T.M., Hoffmann, P.F., Singh, M., Palermo, L., Bilezikian, J.P., Greenspan, S.L. et al. (2008) Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 23(12): 1974-1982.
49.
Krieg, M.A., Cornuz, J., Ruffieux, C., Van Melle, G., Buche, D., Dambacher, M.A. et al. (2006) Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study . J Bone Miner Res21: 1457-1463.
50.
Krug, R., Banerjee, S., Han, E.T., Newitt, D.C., Link, T.M. and Majumdar, S. ( 2005) Feasibility of in vivo structural analysis of high-resolution magnetic resonance images of the proximal femur. Osteoporos Int16: 1307-1314.
51.
Kuchuk, N.O., Van Schoor, N.M., Pluijm, S.M., Chines, A. and Lips, P. ( 2009) Vitamin D status, parathyroid function, bone turnover, and bmd in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res24: 693-701.
52.
Lang, T.F., Cauley, J., Tylavsky, F., Bauer, D., Cummings, S. and Harris, T.for the Health ABC Study (2009) Computed tomography measurement soft high muscle cross-sectional area and attenuation coefficient predict hip fracture: the Health, Agingand Body Composition Study. J Bone Miner Res: Epub 4 Aug 2009.
53.
Lee, J.S., Lacroix, A.Z., Wu, L., Cauley, J.A., Jackson, R.D., Kooperberg, C. et al. (2008) Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women . J Clin Endocrinol Metab93: 1796-1803.
54.
Leslie, W.D., Pahlavan, P.S., Tsang, J.F. and Lix, L.M.(2009) Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int20: 1767-1774.
55.
Lewiecki, E.M. and Borges, J.L. ( 2006) Bone density testing in clinical practice. Arq Bras Endocrinol Metabol50: 586-595.
56.
Lewiecki, E.M., Keaveny, T.M., Kopperdahl, D.L., Genant, H.K., Engelke, K., Fuerst, T. et al. (2009) Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab94: 171-180.
57.
Lips, P., Graafmans, W.C., Ooms, M.E., Bezemer, P.D. and Bouter, L.M. ( 1996) Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med124: 400-406.
58.
Lyles, K.W., Colon Emeric, C.S., Magaziner, J.S., Adachi, J.D., Pieper, C.F., Mautalen, C. et al. (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med357: nihpa40967.
59.
Marshall, D., Johnell, O. and Wedel, H. ( 1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ312: 1254-1259.
60.
McClung, M.R., Geusens, P., Miller, P.D., Zippel, H., Bensen, W.G., Roux, C. et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med344: 333-340.
61.
Medici, M., Van Meurs, J.B., Rivadeneira, F., Zhao, H., Arp, P.P., Hofman, A. et al. (2006) BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study. J Bone Miner Res21: 845-854.
62.
Melton 3rd, L.J., Atkinson, E.J., O’Fallon, W.M., Wahner, H.W. and Riggs, B.L. ( 1993) Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res8: 1227-1233.
63.
Meunier, P.J., Roux, C., Seeman, E., Ortolani, S., Badurski, J.E., Spector, T.D. et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med350: 459-468.
64.
Moffett, S.P., Zmuda, J.M., Oakley, J.I., Beck, T.J., Cauley, J.A., Stone, K.L. et al. (2005) Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab90: 3491-3497.
65.
National Osteoporosis Foundation (2008) Clinician’s guide to prevention and treatment of osteoporosis, Vol. 2009, National Osteoporosis Foundation: Washington.
66.
Nevitt, M.C. and Cummings, S.R. ( 1993) Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 41(11): 1226-1234.
67.
Nguyen, N.D., Pongchaiyakul, C., Center, J.R., Eisman, J.A. and Nguyen, T.V. ( 2005) Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Mineral Res20: 1921-1928, http://www.garvan.org.au/promotions/bone-fracturerisk/calculator/ .
68.
Pulkkinen, P., Jamsa, T., Lochmuller, E.M., Kuhn, V., Nieminen, M.T. and Eckstein, F. ( 2008) Experimental hip fracture load can be predicted from plain radiography by combined analysis of trabecular bone structure and bone geometry . Osteoporos Int19: 547-558.
69.
Pulkkinen, P., Partanen, J., Jalovaara, P. and Jamsa, T. ( 2009) BMD T-score discriminates trochanteric fractures from unfractured controls, whereas geometry discriminates cervical fracture cases from unfractured controls of similar BMD. Osteoporos Int: Epub 26 Sept 2009.
70.
Reginster, J.Y., Seeman, E., De Vernejoul, M.C., Adami, S., Compston, J., Phenekos, C. et al. (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab90: 2816-2822.
71.
Reginster, J.Y., Malaise, O., Neuprez, A. and Bruyere, O. ( 2007) Strontium ranelate in the prevention of osteoporotic fractures . Int J Clin Pract61: 324-328.
72.
Reginster, J.Y., Bruyere, O., Sawicki, A., Roces Varela, A., Fardellone, P., Roberts, A. et al. (2009) Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Bone45: 1059-1064.
73.
Richards, J.B., Rivadeneira, F., Inouye, M., Pastinen, T.M., Soranzo, N., Wilson, S.G. et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet371: 1505-1512.
74.
Richards, J.B., Kavvoura, F.K., Rivadeneira, F., Styrkarsdottir, U., Estrada, K., Halldorsson, B.V. et al. (2009) Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med151: 528-537.
75.
Rivadeneira, F., Van Meurs, J.B., Kant, J., Zillikens, M.C., Stolk, L., Beck, T.J. et al. (2006) Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res21: 1443-1456.
76.
Rivadeneira, F., Zillikens, M.C., De Laet, C.E., Hofman, A., Uitterlinden, A.G., Beck, T.J. et al. (2007) Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study. J Bone Miner Res22: 1781-1790.
77.
Rivadeneira, F., Styrkarsdottir, U., Estrada, K., Halldorsson, B.V., Hsu, Y.H., Richards, J.B. et al. (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet41: 1199-1206.
78.
Robbins, J.A., Schott, A.M., Garnero, P., Delmas, P.D., Hans, D. and Meunier, P.J. ( 2005) Risk factors for hip fracture in women with high BMD: EPIDOS Study. Osteoporos Int16: 149-154.
79.
Robbins, J., Aragaki, A.K., Kooperberg, C., Watts, N., Wactawski Wende, J., Jackson, R.D. et al. (2007) Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA298: 2389-2398.
80.
Rolland, Y., Abellan Van Kan, G., Bénétos, A., Blain, H., Bonnefoy, M., Chassagne, P. et al. (2008) Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging12: 335-346.
81.
Ryg, J., Rejnmark, L., Overgaard, S., Brixen, K. and Vestergaard, P. ( 2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001 . J Bone Miner Res24: 1299-1307.
82.
Saag, K.G. and Geusens, P.(2009) Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Ther11: 251.
83.
Saito, M., Fujii, K. and Marumo, K. ( 2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls . Calcif Tissue Int79: 160-168.
84.
Sambrook, P. and Cooper, C. ( 2006) Osteoporosis. Lancet367: 2010-2018.
85.
Sandhu, S.K., Nguyen, N.D., Center, J.R., Pocock, N.A., Eisman, J.A. and Nguyen, T.V. ( 2009) Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int: Epub 25 Jul 2009.
86.
Schott, A.M., Cormier, C., Hans, D., Favier, F., Hausherr, E., Dargent-Molina, P. et al. (1998) How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study. Osteoporos Int8: 247-254.
87.
Stewart, A.D. and Hannan, J. ( 2000) Total and regional bone density in male runners, cyclists, and controls. Med Sci Sports Exerc32: 1373-1377.
88.
Stone, K., Seeley, D., Lui, L., Cauley, J., Ensrud, K.E., Browner, W. et al. (2003) BMD at multiple sites and risk of fracture of multiple types: long-term fracture prediciton. J Bone Miner Res18: 12-18.
89.
Styrkarsdottir, U., Halldorsson, B.V., Gretarsdottir, S., Gudbjartsson, D.F., Walters, G.B., Ingvarsson, T. et al. (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med358: 2355-2365.
90.
Szulc, P., Chapuy, M.C., Meunier, P.J. and Delmas, P.D. ( 1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest91: 1769-1774.
91.
Szulc, P., Duboeuf, F., Schott, A.M., Dargent Molina, P., Meunier, P.J. and Delmas, P.D. ( 2006) Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS Study. Osteoporos Int17: 231-236.
92.
Testi, D., Viceconti, M., Baruffaldi, F. and Cappello, A. ( 1999) Risk of fracture in elderly patients: a new predictive index based on bone mineral density and finite element analysis. Comput Methods Programs Biomed60: 23-33.
93.
Testi, D., Viceconti, M., Cappello, A. and Gnudi, S. ( 2002) Prediction of hip fracture can be significantly improved by a single biomedical indicator. Ann Biomed Eng30: 801-807.
94.
van Geel, T.A., van Helden, S., Geusens, P.P., Winkens, B. and Dinant, G.J.(2009) Clinical subsequent fractures cluster in time after first fractures . Ann Rheum Dis. 68(1): 99-102.
95.
van Helden, S., Cals, J., Kessels, F., Brink, P., Dinant, G.J. and Geusens, P. ( 2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int. 17(3): 348-354.
96.
Vergnaud, P., Garnero, P., Meunier, P.J., Breart, G., Kamihagi, K. and Delmas, P.D. ( 1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab82: 719-724.
97.
Wainwright, S.A., Marshall, L.M., Ensrud, K.E., Cauley, J.A., Black, D.M., Hillier, T.A. et al. (2005) Hip fracture in women without osteoporosis . J Clin Endocrinol Metab90: 2787-2793.
98.
WHO. FRAX WHO Fracture Risk Assessment Tool, Web version 3.0 ed.
99.
Yang, Q., Khoury, M.J., Friedman, J.M. and Flanders, W.D. ( 2003) On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology14: 161-167.
100.
Young, W.C. ( 1989) Elastic stability formulas for stress and strain, In: Young, W.C.,Budynas, R.G. and Roark, R.J. (eds), Roark’s formulas for stress and strain, 6th edn, McGraw-Hill: New York.
